Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact
2024

Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents

Sample size: 36 publication 10 minutes Evidence: moderate

Author Information

Author(s): Bertuzzi Clara, Righi Simona, Motta Giovanna, Rossi Maura, Carella Matteo, Gabrielli Giulia, Facchini Elena, Baldassarre Maurizio, Prete Arcangelo, Zinzani Pier Luigi, Mascolo Massimo, Agostinelli Claudio, Sabattini Elena

Primary Institution: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Hypothesis

What are the immune checkpoint inhibitors therapeutic targets and specific T-cell subsets in adolescent patients with Classical Hodgkin’s lymphoma?

Conclusion

The study found that the microenvironment of Classical Hodgkin’s lymphoma in adolescents contains potential therapeutic targets for immune checkpoint inhibitors.

Supporting Evidence

  • All cases expressed immune checkpoint molecules CTLA-4, LAG-3, and PD-1.
  • A higher risk of recurrence and progression occurred in patients with lower amounts of CD8+ T-cells.
  • The presence of PD-1+ T-cells was associated with advanced stage disease.
  • CTLA-4 was the most represented immune checkpoint molecule in the microenvironment.

Takeaway

This study looked at young people with a type of cancer called Hodgkin's lymphoma and found that their cancer environment has special features that could help doctors treat them better.

Methodology

The study analyzed formalin-fixed paraffin-embedded tissue samples from adolescent patients diagnosed with Classical Hodgkin’s lymphoma using immunohistochemistry to assess immune checkpoint molecules and biological markers.

Potential Biases

Potential biases may arise from the retrospective nature of the study and the specific patient population.

Limitations

The study is limited to a specific age group and may not be generalizable to all Hodgkin's lymphoma patients.

Participant Demographics

Participants were adolescents aged 12 to 18 years, with a majority being female (55.6%).

Statistical Information

P-Value

0.032

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cancers16244210

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication